These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3443056)

  • 21. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
    Motz W; Strauer BE
    Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
    Maxwell MH
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The optimal blood pressure reduction.
    Hansson L
    J Hypertens Suppl; 1996 Sep; 14(2):S55-8; discussion S58-9. PubMed ID: 8934379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure normalization is associated with normal left ventricular mass but not carotid geometry: the ICARe Dicomano Study.
    Pini R; Cavallini MC; Staglianò L; Tarantini F; Marchionni N; Di Bari M; Devereux RB; Masotti G; Roman MJ
    J Hypertens; 2006 May; 24(5):973-9. PubMed ID: 16612261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension therapy: current and future strategies.
    Pardell H
    J Int Med Res; 1988; 16 Suppl 1():2A-7A. PubMed ID: 3065098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures.
    Greenberg J
    Am J Hypertens; 2005 Aug; 18(8):1033-9. PubMed ID: 16109316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major new developments affecting treatment and prognosis in hypertension.
    Gubner RS
    Trans Assoc Life Insur Med Dir Am; 1990; 73():97-114. PubMed ID: 2353405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications.
    Asmar R
    Am J Cardiovasc Drugs; 2001; 1(5):387-97. PubMed ID: 14728020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy.
    Vergnaud AC; Protogerou AD; Blacher J; Safar ME
    J Hypertens; 2008 Jan; 26(1):138-44. PubMed ID: 18090551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.
    Samuelsson O
    Acta Med Scand Suppl; 1985; 702():1-79. PubMed ID: 3866485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.